These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 23689884

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Response of laboratory staff to vaccination with an inactivated Rift Valley fever vaccine--TSI-GSD 200.
    Frank-Peterside N.
    Afr J Med Med Sci; 2000 Jun; 29(2):89-92. PubMed ID: 11379456
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Stability of a formalin-inactivated Rift Valley fever vaccine: evaluation of a vaccination campaign for cattle in Mozambique.
    Lagerqvist N, Moiane B, Bucht G, Fafetine J, Paweska JT, Lundkvist A, Falk KI.
    Vaccine; 2012 Oct 12; 30(46):6534-40. PubMed ID: 22947138
    [Abstract] [Full Text] [Related]

  • 10. Exotic Animal Diseases Bulletin: Rift Valley fever.
    Aust Vet J; 2007 Jun 12; 85(6):N18-9. PubMed ID: 17632949
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Rift Valley fever in Kenya: history of epizootics and identification of vulnerable districts.
    Murithi RM, Munyua P, Ithondeka PM, Macharia JM, Hightower A, Luman ET, Breiman RF, Njenga MK.
    Epidemiol Infect; 2011 Mar 12; 139(3):372-80. PubMed ID: 20478084
    [Abstract] [Full Text] [Related]

  • 14. One Health approach to Rift Valley fever vaccine development.
    Kortekaas J.
    Antiviral Res; 2014 Jun 12; 106():24-32. PubMed ID: 24681125
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Identifying Areas Suitable for the Occurrence of Rift Valley Fever in North Africa: Implications for Surveillance.
    Arsevska E, Hellal J, Mejri S, Hammami S, Marianneau P, Calavas D, Hénaux V.
    Transbound Emerg Dis; 2016 Dec 12; 63(6):658-674. PubMed ID: 25655790
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep.
    Dungu B, Louw I, Lubisi A, Hunter P, von Teichman BF, Bouloy M.
    Vaccine; 2010 Jun 23; 28(29):4581-7. PubMed ID: 20470792
    [Abstract] [Full Text] [Related]

  • 18. Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus.
    Näslund J, Lagerqvist N, Habjan M, Lundkvist A, Evander M, Ahlm C, Weber F, Bucht G.
    Virology; 2009 Mar 15; 385(2):409-15. PubMed ID: 19157482
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of a formalin-inactivated Rift Valley fever vaccine in sheep.
    Harrington DG, Lupton HW, Crabbs CL, Peters CJ, Reynolds JA, Slone TW.
    Am J Vet Res; 1980 Oct 15; 41(10):1559-64. PubMed ID: 7224281
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.